2018-2023 Global Irritable Bowel Syndrome (IBS) Consumption Market Report

Publisher Name :
Date: 20-Sep-2018
No. of pages: 134

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Irritable Bowel Syndrome (IBS) market for 2018-2023.

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

Currently, the IBS treatment market is naïve and underpenetrated, with 4 products indicated for IBS in the market. These include the IBS-C therapies, Amitiza (lubiprostone, Sucampo/Takeda) and Linzess (linaclotide, Ironwood/Allergan/Astellas); and the IBS-D therapies, Lotronex (Sebela Pharmaceuticals) and Irribow (ramosetron, Astellas). Antidepressants and antibiotics (mainly Xifaxan [rifaximin], Valeant) are also used off-label to treat IBS.

The IBS treatment market is characterized by significant unmet needs, which include the need for products with improved efficacy, products for the treatment of the IBS-D and IBS-M subtypes, and products that effectively address IBS symptoms, such as abdominal pain and bloating, as well as the requirement for the improved diagnosis of IBS. As a result, there are significant opportunities in the uncrowded IBS therapeutics market.

Over the next five years, LPI(LP Information) projects that Irritable Bowel Syndrome (IBS) will register a 16.3% CAGR in terms of revenue, reach US$ 6530 million by 2023, from US$ 2640 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Irritable Bowel Syndrome (IBS) market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- IBS-D Drug

- IBS-C Drug

- Other

Segmentation by application:

- Women

- Men

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- Allergan

- Valeant Pharmaceuticals

- Takeda

- Sucampo Pharmaceuticals

- McNeil Consumer Healthcare

- Sebela Pharmaceuticals

- Astellas Pharmaceuticals

- IM HealthScience

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Irritable Bowel Syndrome (IBS) consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Irritable Bowel Syndrome (IBS) market by identifying its various subsegments.

- Focuses on the key global Irritable Bowel Syndrome (IBS) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Irritable Bowel Syndrome (IBS) with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Irritable Bowel Syndrome (IBS) submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global Irritable Bowel Syndrome (IBS) Consumption Market Report

Table of Contents

2018-2023 Global Irritable Bowel Syndrome (IBS) Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome (IBS) Consumption 2013-2023
2.1.2 Irritable Bowel Syndrome (IBS) Consumption CAGR by Region
2.2 Irritable Bowel Syndrome (IBS) Segment by Type
2.2.1 IBS-D Drug
2.2.2 IBS-C Drug
2.2.3 Other
2.3 Irritable Bowel Syndrome (IBS) Consumption by Type
2.3.1 Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
2.3.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2013-2018)
2.3.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Type (2013-2018)
2.4 Irritable Bowel Syndrome (IBS) Segment by Application
2.4.1 Women
2.4.2 Men
2.5 Irritable Bowel Syndrome (IBS) Consumption by Application
2.5.1 Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
2.5.2 Global Irritable Bowel Syndrome (IBS) Value and Market Share by Application (2013-2018)
2.5.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Application (2013-2018)

3 Global Irritable Bowel Syndrome (IBS) by Players
3.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players
3.1.1 Global Irritable Bowel Syndrome (IBS) Sales by Players (2016-2018)
3.1.2 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players (2016-2018)
3.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players
3.2.1 Global Irritable Bowel Syndrome (IBS) Revenue by Players (2016-2018)
3.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2016-2018)
3.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Players
3.4 Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Irritable Bowel Syndrome (IBS) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Irritable Bowel Syndrome (IBS) by Regions
4.1 Irritable Bowel Syndrome (IBS) by Regions
4.1.1 Global Irritable Bowel Syndrome (IBS) Consumption by Regions
4.1.2 Global Irritable Bowel Syndrome (IBS) Value by Regions
4.2 Americas Irritable Bowel Syndrome (IBS) Consumption Growth
4.3 APAC Irritable Bowel Syndrome (IBS) Consumption Growth
4.4 Europe Irritable Bowel Syndrome (IBS) Consumption Growth
4.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Growth

5 Americas
5.1 Americas Irritable Bowel Syndrome (IBS) Consumption by Countries
5.1.1 Americas Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018)
5.1.2 Americas Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018)
5.2 Americas Irritable Bowel Syndrome (IBS) Consumption by Type
5.3 Americas Irritable Bowel Syndrome (IBS) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Irritable Bowel Syndrome (IBS) Consumption by Countries
6.1.1 APAC Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018)
6.1.2 APAC Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018)
6.2 APAC Irritable Bowel Syndrome (IBS) Consumption by Type
6.3 APAC Irritable Bowel Syndrome (IBS) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) by Countries
7.1.1 Europe Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018)
7.1.2 Europe Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018)
7.2 Europe Irritable Bowel Syndrome (IBS) Consumption by Type
7.3 Europe Irritable Bowel Syndrome (IBS) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Irritable Bowel Syndrome (IBS) by Countries
8.1.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018)
8.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Type
8.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Irritable Bowel Syndrome (IBS) Distributors
10.3 Irritable Bowel Syndrome (IBS) Customer

11 Global Irritable Bowel Syndrome (IBS) Market Forecast
11.1 Global Irritable Bowel Syndrome (IBS) Consumption Forecast (2018-2023)
11.2 Global Irritable Bowel Syndrome (IBS) Forecast by Regions
11.2.1 Global Irritable Bowel Syndrome (IBS) Forecast by Regions (2018-2023)
11.2.2 Global Irritable Bowel Syndrome (IBS) Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Irritable Bowel Syndrome (IBS) Forecast by Type
11.8 Global Irritable Bowel Syndrome (IBS) Forecast by Application

12 Key Players Analysis
12.1 Allergan
12.1.1 Company Details
12.1.2 Irritable Bowel Syndrome (IBS) Product Offered
12.1.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Allergan News
12.2 Valeant Pharmaceuticals
12.2.1 Company Details
12.2.2 Irritable Bowel Syndrome (IBS) Product Offered
12.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Valeant Pharmaceuticals News
12.3 Takeda
12.3.1 Company Details
12.3.2 Irritable Bowel Syndrome (IBS) Product Offered
12.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Takeda News
12.4 Sucampo Pharmaceuticals
12.4.1 Company Details
12.4.2 Irritable Bowel Syndrome (IBS) Product Offered
12.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Sucampo Pharmaceuticals News
12.5 McNeil Consumer Healthcare
12.5.1 Company Details
12.5.2 Irritable Bowel Syndrome (IBS) Product Offered
12.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 McNeil Consumer Healthcare News
12.6 Sebela Pharmaceuticals
12.6.1 Company Details
12.6.2 Irritable Bowel Syndrome (IBS) Product Offered
12.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Sebela Pharmaceuticals News
12.7 Astellas Pharmaceuticals
12.7.1 Company Details
12.7.2 Irritable Bowel Syndrome (IBS) Product Offered
12.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Astellas Pharmaceuticals News
12.8 IM HealthScience
12.8.1 Company Details
12.8.2 Irritable Bowel Syndrome (IBS) Product Offered
12.8.3 IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 IM HealthScience News

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Irritable Bowel Syndrome (IBS)
Table Product Specifications of Irritable Bowel Syndrome (IBS)
Figure Irritable Bowel Syndrome (IBS) Report Years Considered
Figure Market Research Methodology
Figure Global Irritable Bowel Syndrome (IBS) Consumption Growth Rate 2013-2023 (K Units)
Figure Global Irritable Bowel Syndrome (IBS) Value Growth Rate 2013-2023 ($ Millions)
Table Irritable Bowel Syndrome (IBS) Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of IBS-D Drug
Table Major Players of IBS-D Drug
Figure Product Picture of IBS-C Drug
Table Major Players of IBS-C Drug
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Revenue by Type (2013-2018) ($ million)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Irritable Bowel Syndrome (IBS) Value Market Share by Type (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Sale Price by Type (2013-2018)
Figure Irritable Bowel Syndrome (IBS) Consumed in Women
Figure Global Irritable Bowel Syndrome (IBS) Market: Women (2013-2018) (K Units)
Figure Global Irritable Bowel Syndrome (IBS) Market: Women (2013-2018) ($ Millions)
Figure Global Women YoY Growth ($ Millions)
Figure Irritable Bowel Syndrome (IBS) Consumed in Men
Figure Global Irritable Bowel Syndrome (IBS) Market: Men (2013-2018) (K Units)
Figure Global Irritable Bowel Syndrome (IBS) Market: Men (2013-2018) ($ Millions)
Figure Global Men YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Value by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share by Application (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Value Market Share by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Sale Price by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Sales by Players (2016-2018) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players (2016-2018)
Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players in 2016
Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players in 2017
Table Global Irritable Bowel Syndrome (IBS) Revenue by Players (2016-2018) ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2016-2018)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players in 2016
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players in 2017
Table Global Irritable Bowel Syndrome (IBS) Sale Price by Players (2016-2018)
Figure Global Irritable Bowel Syndrome (IBS) Sale Price by Players in 2017
Table Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution and Sales Area by Players
Table Players Irritable Bowel Syndrome (IBS) Products Offered
Table Irritable Bowel Syndrome (IBS) Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Irritable Bowel Syndrome (IBS) Consumption by Regions 2013-2018 (K Units)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Regions 2013-2018
Figure Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Regions 2013-2018
Table Global Irritable Bowel Syndrome (IBS) Value by Regions 2013-2018 ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share by Regions 2013-2018
Figure Global Irritable Bowel Syndrome (IBS) Value Market Share by Regions 2013-2018
Figure Americas Irritable Bowel Syndrome (IBS) Consumption 2013-2018 (K Units)
Figure Americas Irritable Bowel Syndrome (IBS) Value 2013-2018 ($ Millions)
Figure APAC Irritable Bowel Syndrome (IBS) Consumption 2013-2018 (K Units)
Figure APAC Irritable Bowel Syndrome (IBS) Value 2013-2018 ($ Millions)
Figure Europe Irritable Bowel Syndrome (IBS) Consumption 2013-2018 (K Units)
Figure Europe Irritable Bowel Syndrome (IBS) Value 2013-2018 ($ Millions)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption 2013-2018 (K Units)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Value 2013-2018 ($ Millions)
Table Americas Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018) (K Units)
Table Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries (2013-2018)
Figure Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries in 2017
Table Americas Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018) ($ Millions)
Table Americas Irritable Bowel Syndrome (IBS) Value Market Share by Countries (2013-2018)
Figure Americas Irritable Bowel Syndrome (IBS) Value Market Share by Countries in 2017
Table Americas Irritable Bowel Syndrome (IBS) Consumption by Type (2013-2018) (K Units)
Table Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Figure Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Type in 2017
Table Americas Irritable Bowel Syndrome (IBS) Consumption by Application (2013-2018) (K Units)
Table Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Figure Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Application in 2017
Figure United States Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure United States Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Canada Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Canada Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Mexico Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Mexico Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Table APAC Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018) (K Units)
Table APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries (2013-2018)
Figure APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries in 2017
Table APAC Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018) ($ Millions)
Table APAC Irritable Bowel Syndrome (IBS) Value Market Share by Countries (2013-2018)
Figure APAC Irritable Bowel Syndrome (IBS) Value Market Share by Countries in 2017
Table APAC Irritable Bowel Syndrome (IBS) Consumption by Type (2013-2018) (K Units)
Table APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Figure APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Type in 2017
Table APAC Irritable Bowel Syndrome (IBS) Consumption by Application (2013-2018) (K Units)
Table APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Figure APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Application in 2017
Figure China Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure China Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Japan Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Japan Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Korea Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Korea Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure India Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure India Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Australia Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Australia Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Table Europe Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries in 2017
Table Europe Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018) ($ Millions)
Table Europe Irritable Bowel Syndrome (IBS) Value Market Share by Countries (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Value Market Share by Countries in 2017
Table Europe Irritable Bowel Syndrome (IBS) Consumption by Type (2013-2018) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Type in 2017
Table Europe Irritable Bowel Syndrome (IBS) Consumption by Application (2013-2018) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Application in 2017
Figure Germany Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Germany Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure France Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure France Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure UK Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure UK Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Italy Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Italy Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Russia Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Russia Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Spain Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Spain Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries in 2017
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Value Market Share by Countries in 2017
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Type in 2017
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Application in 2017
Figure Egypt Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Egypt Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure South Africa Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure South Africa Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Israel Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Israel Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Turkey Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Turkey Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Table Irritable Bowel Syndrome (IBS) Distributors List
Table Irritable Bowel Syndrome (IBS) Customer List
Figure Global Irritable Bowel Syndrome (IBS) Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Irritable Bowel Syndrome (IBS) Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Forecast by Regions
Table Global Irritable Bowel Syndrome (IBS) Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share Forecast by Regions
Figure Americas Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Americas Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure APAC Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure APAC Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Europe Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Europe Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure United States Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure United States Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Canada Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Canada Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Mexico Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Mexico Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Brazil Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Brazil Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure China Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure China Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Japan Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Japan Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Korea Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Korea Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure India Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure India Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Australia Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Australia Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Germany Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Germany Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure France Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure France Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure UK Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure UK Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Italy Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Italy Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Russia Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Russia Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Spain Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Spain Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Egypt Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Egypt Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure South Africa Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure South Africa Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Israel Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Israel Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Turkey Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Turkey Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure GCC Countries Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure GCC Countries Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Consumption Forecast by Type (2018-2023) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Share Forecast by Type (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Value Forecast by Type (2018-2023) ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share Forecast by Type (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Consumption Forecast by Application (2018-2023) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Share Forecast by Application (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Value Forecast by Application (2018-2023) ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share Forecast by Application (2018-2023)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Allergan Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table Valeant Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Takeda Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table Sucampo Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table McNeil Consumer Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table Sebela Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table Astellas Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table IM HealthScience Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure IM HealthScience Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Vinylphosphonic Acid Dimethylester Market 2018, Forecast to 2023
    Published: 10-Dec-2018        Price: US 4880 Onwards        Pages: 115
    Vinylphosphonic acid and vinylphosphonic acid dimethylester are produced in chloride free processes and are supplied in a high quality with two different water contents. Vinylphosphonic acid (VPA), its polymers and copolymers has outstanding properties in several application areas due to the presence of both lipophilic and hydrophilic functionalities in one molecule. These products are particularly suitable for the improvement of material properties and surfaces such as coatings, corrosion inhib......
  • Global and Chinese Esomeprazole Industry, 2018 Market Research Report
    Published: 09-Dec-2018        Price: US 3000 Onwards        Pages: 145
    The 'Global and Chinese Esomeprazole Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Esomeprazole industry with a focus on the Chinese market. The report provides key statistics on the market status of the Esomeprazole manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, ap......
  • Global and Chinese Diarrhea Drug Industry, 2018 Market Research Report
    Published: 07-Dec-2018        Price: US 3000 Onwards        Pages: 137
    The 'Global and Chinese Diarrhea Drug Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Diarrhea Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Diarrhea Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition,......
  • Global and Chinese Anti Peptic Ulcer Drugs Industry, 2018 Market Research Report
    Published: 01-Dec-2018        Price: US 3000 Onwards        Pages: 142
    The 'Global and Chinese Anti Peptic Ulcer Drugs Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Anti Peptic Ulcer Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Anti Peptic Ulcer Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the indu......
  • Global and Chinese Irritable Bowel Syndrome (IBS) Industry, 2018 Market Research Report
    Published: 30-Nov-2018        Price: US 3000 Onwards        Pages: 139
    The 'Global and Chinese Irritable Bowel Syndrome (IBS) Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Irritable Bowel Syndrome (IBS) industry with a focus on the Chinese market. The report provides key statistics on the market status of the Irritable Bowel Syndrome (IBS) manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic......
  • Global and Chinese Gastrointestinal Drugs Industry, 2018 Market Research Report
    Published: 30-Nov-2018        Price: US 3000 Onwards        Pages: 136
    The 'Global and Chinese Gastrointestinal Drugs Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Gastrointestinal Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Gastrointestinal Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industr......
  • Global and Chinese Anti-Peptic Ulcer Drugs Industry, 2018 Market Research Report
    Published: 28-Nov-2018        Price: US 3000 Onwards        Pages: 145
    The 'Global and Chinese Anti-Peptic Ulcer Drugs Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Anti-Peptic Ulcer Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Anti-Peptic Ulcer Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the indu......
  • Global Inflammatory Bowel Disease Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 118
    Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most common inflammatory bowel diseases are ulcerative colitis and Crohns disease. Scope of the Report: The growth in prevalence of inflammatory bowel diseases such as ulcerative colitis and Crohn's disease majorly drives the growth of the market. In addition, increase in intake of unhealthy food and drinks, and sedentary and stressf......
  • Global Diarrhea Drug Market Data Survey Report 2025
    Published: 21-Nov-2018        Price: US 1500 Onwards        Pages: 75
    Summary The global Diarrhea Drug market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capacity and pr......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs